期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非他汀类调脂药物应用地位评价 被引量：2

原文传递
导出
摘要 他汀类药物通过抑制肝细胞内胆固醇合成,可有效降低血胆固醇特别是LDL-C浓度,延缓甚或消退动脉粥样硬化斑块,明显减少冠心病的发病率和死亡率.由于这类药物在动脉粥样硬化性心血管疾病（ASCVD）的一级和二级预防中作用十分显著,是干预血脂异常、预防ASCVD的一线基础用药,临床应用十分广泛.
作者 赵水平 陈雅琴
机构地区 中南大学湘雅二医院心内科
出处 《中华内科杂志》 CAS CSCD 北大核心 2015年第4期284-287,共4页 Chinese Journal of Internal Medicine
关键词 临床应用 他汀类调脂药物 动脉粥样硬化性心血管疾病 动脉粥样硬化斑块 他汀类药物 二级预防 胆固醇合成 ASCVD
分类号 R972 [医药卫生—药品]
  • 相关文献

参考文献19

  • 1Farmer JA. Simvastatin with or without ezetimibe in familial hypercholesterolemia (the ENHANCE trial) [J]. Curr Atheroscler Rep,2009 ,11(2) :81-82.
  • 2Villines TC, Stanek EJ, Devine PJ, et al. The ARBITER 6- HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis ): final results and the impact of medication adherence, dose, and treatment duration [J]. J Am Coil Cardiol,2010,55(24) : 2721-2726.
  • 3Taylor A J, Villines TC, Stanek EJ. Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe [ J ]. Eur Heart J, 2012,33 ( 23 ) : 2939- 2945.
  • 4Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection) : a randomised placebo-controlled trial [ J ]. Lancet, 2011, 377 (9784) : 2181-2192.
  • 5Huijgen R, Abbink EJ, Bruckert E, et al. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia : a 12-week, multicenter, randomized, double-blind, controlled trial[ J]. Clin Ther, 2010, 32(4) :615-625.
  • 6Yamamoto S, Tanigawa H, Li X, et al. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels butpromotes reverse cholesterol trarsport[ J]. Circulation,2011,124 (12) :1382-1390.
  • 7新型调脂植物药——多廿烷醇临床应用专家共识[J].中华内科杂志,2008,47(11):961-963. 被引量：16
  • 8刘顺,谭茗月,赵水平,荣惠.多廿烷醇对高脂血症患者血脂谱和血红素氧合酶1的作用[J].中华心血管病杂志,2012,40(10):840-843. 被引量：10
  • 9Backes JM, Gibson CA, Ruisinger JF, et al. Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy [ J ]. Lipids ,2011,46 ( 10 ) : 923-929.
  • 10AIM-HIGH Investigators, Bodcn WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy[J]. N Engl J Med, 2011,365(24) : 2255-2267.

二级参考文献29

  • 1Singh DK, Li L, Porter TD. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J Pharmacol Exp Ther,2006 ,318 :1020-1026.
  • 2Menendez R, Fraga V, Amor AM, et al. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation. Physiol Behav, 1999,67 : 1-7.
  • 3Noa M, Mas R, de la Rosa MC, et al. Effect of policosanol on lipofundin-induced atherosclerotic lesions in rats. J Pharm Pharmacol, 1995,47 : 289 -291.
  • 4Noa M, de la Rosa MC, Mas R. Effect of policosanol on foam-cell formation in carrageenan-induced granulomas in rats. J Pharm Pharmacol, 1996,48:306-309.
  • 5Castano G, Mas R, Fernandez L, et al. Effects of policosanol and lovastatin in patients with intermittent clandication: a double-blind comparative pilot study. Angiology, 2003,54 : 25 -38.
  • 6Illnait J, Castano G, Alvarez E, et al. Effects of policosanol ( 10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication : a 10-week, randomized, comparative study. Angiology, 2008,59 : 269 -277.
  • 7Castano G, Mas R, Fernandez L, et al. Effects of policosanol on patients with borderline to mildly increased serum cholesterol levels: a prospective, double-blinded placebo-controlled study. Curr Ther Res Clin,2003 ,64 :522-537.
  • 8Femandez S, Mas R, Gamez R, et al. A pharmacological surveillance study of the tolerability of policosanol in the elderly population. Am J Geriatr Pharmaeother, 2004,2:219-229.
  • 9Noa M, Mendoza S, Mas R, et al. Effect of policosanol on carbon tetrachloride-induced acute liver damage in Sprague-Dawley rats. Drugs R D, 2003,4:29-35.
  • 10Castano G, Mas R, Arruzazabala ML, et al. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. Int J Clin Pharmacol Res, 1999,19 : 105-116.

共引文献18

同被引文献18

  • 1吴文静,柯元南.华法林与氯沙坦、非诺贝特及别嘌醇伍用致上消化道出血[J].药物不良反应杂志,2005,7(1):59-60. 被引量：3
  • 2Introduction[J]. Diabetes Care, 2015,38 Suppl:S1-S2.
  • 3Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American association of clinical endocrinologists and american college of endocrinology-clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015[J]. Endocr Pract,2015,21 Suppl 1:1-87.
  • 4Stone NJ, Robinson JG, Lichtenstein AH, et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2014,63(25 Pt B):2889-2934.
  • 5Meek C, Wierzbicki AS,Jewkes C,et al. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients : an observational study[J]. Curr Med Res Opin, 2012,28(3):371-378.
  • 6ACCORD Study Group,Ginsberg HN,Elam MB, et al. Effects of combination lipid therapy in type 2 diabetes mellitus[J]. N Engl J Med,2010,362(17);1563-1574.
  • 7Ziaeian B, Dinkier J, Watson K. Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes : Vytorin Efficacy International Trial[J]. Rev Cardiovasc Med, 2015 , 16(2):125-130.
  • 8Jones PH,Davidson MH. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin[J]. Am J Cardiol,2005,95(1):120-122.
  • 9AIM-HIGH Investigators, Boden WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy[J]. N Engl J Med,2011,365(24):2255-2267.
  • 10Rajpathak SN,Kumbhani DJ,Crandall J,et al. Statin therapy and risk of developing type 2 diabetes : a meta-analysis[J]. Diabetes Care,2009,32(10):1924-1929.

引证文献2

二级引证文献4

中华内科杂志
2015年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部